0000000000413535

AUTHOR

Ester Hernández

showing 2 related works from this author

Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity

2013

The microbiomes in the gastrointestinal tract (GIT) of individuals receiving antibiotics and those in obese subjects undergo compositional shifts, the metabolic effects and linkages of which are not clearly understood. Herein, we set to gain insight into these effects, particularly with regard to carbohydrate metabolism, and to contribute to unravel the underlying mechanisms and consequences for health conditions. We measured the activity level of GIT carbohydrate-active enzymes toward 23 distinct sugars in adults patients (n = 2) receiving 14-d β-lactam therapy and in obese (n = 7) and lean (n = 5) adolescents. We observed that both 14 d antibiotic-treated and obese subjects showed higher …

MaleobesityAnabolismAntibioticsBody Mass Indexmetabolic reconstructionantibiotic therapySystems and Synthetic Biology2. Zero hungerSysteem en Synthetische Biologie0303 health sciencesGastrointestinal tractMicrobiotaHuman gastrointestinal tractGastroenterologyBiotaAnti-Bacterial Agents3. Good healthInfectious Diseasesmedicine.anatomical_structureglycosidaseCarbohydrate MetabolismFemaleResearch PaperAdultMicrobiology (medical)medicine.medical_specialtyAdolescentmedicine.drug_classCarbohydrate metabolismBiologyMicrobiology03 medical and health sciencesInsulin resistanceInternal medicinemedicineHumansMicrobiomeObesityVLAGAged030304 developmental biologyMetabolic reconstruction030306 microbiologyAntibiotic therapymedicine.diseaseObesityGlycosidaseGastrointestinal TractDistal gutEndocrinologyHyperglycemiaInsulin Resistancedistal gut
researchProduct

Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses

2015

Clostridium difficile-associated diarrhoea (CDAD) is caused by C. difficile toxins A and B and represents a serious emerging health problem. Yet, its progression and functional consequences are unclear. We hypothesised that C. difficile can drive major measurable metabolic changes in the gut microbiota and that a relationship with the production or absence of toxins may be established. We tested this hypothesis by performing metabolic profiling on the gut microbiota of patients with C. difficile that produced (n=6) or did not produce (n=4) toxins and on non-colonised control patients (n=6), all of whom were experiencing diarrhoea. We report a statistically significant separation (P-value o0…

DiarrheaMaleBacterial ToxinsDiseasePathogenesisGut floraMicrobiologyMicrobiologyFecesClostridiumMetabolomicsRNA Ribosomal 16SmedicineMetabolomeHumansMetabolomicsColitisEcology Evolution Behavior and SystematicsbiologyClostridioides difficileClostridium difficilebiology.organism_classificationmedicine.diseaseColitisIntestinesRNA BacterialDiarrheaClostridium InfectionsMetabolomeFemaleOriginal Articlemedicine.symptomBacterial infection
researchProduct